EXPERIMENTAL DESIGN : In a cell culture model of an erlotinib -sensitive EGFR -mutant NSCLC cell line , we tested the hypothesis that prior exposure to platinum agents , a standard component of NSCLC chemotherapy treatment , affects the subsequent response to erlotinib .